These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1797309)

  • 1. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
    Campbell JK; Marshall RJ; Winslow E
    Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
    Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of propafenone on the parameters of body surface electrocardiogram in comparison with those of disopyramide].
    Omori I; Ochiai M; Inoue D; Asayama J; Nakagawa M
    Kokyu To Junkan; 1993 Jul; 41(7):647-52. PubMed ID: 8337528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat.
    Delbressine L; Harris N; Kane KA; Muir AW; Winslow E
    J Pharm Pharmacol; 1992 Dec; 44(12):996-1000. PubMed ID: 1361566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
    Winslow E; Martorana M; Bell P
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):205-12. PubMed ID: 2476592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y; Abe A; Ohira K; Furushima H; Chinushi M; Fujita S
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts.
    Winslow E; Mason R
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):435-41. PubMed ID: 1378126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
    Campbell TJ
    J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and electrophysiological effects in-vivo of the major metabolite of Org 7797 found in canine and rodent liver homogenate preparations.
    Winslow E; Campbell JK; Delbressine L
    J Pharm Pharmacol; 1995 Jul; 47(7):608-13. PubMed ID: 8568630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.